Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Voya Financial
VOYA
|
+$81.9M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$68.8M |
| 3 |
Goldman Sachs
GS
|
+$64.1M |
| 4 |
AbbVie
ABBV
|
+$58.2M |
| 5 |
Citigroup
C
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$85.8M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$60.3M |
| 3 |
Morgan Stanley
MS
|
+$52.6M |
| 4 |
Expedia Group
EXPE
|
+$47.8M |
| 5 |
Centene
CNC
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Financials | 14.02% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NP
1701
DELISTED
Neenah, Inc. Common Stock
NP
| $3.99M | 0.01% |
67,639
-39,009
| -37% | -$2.37M |
|
|
WAGE
1702
DELISTED
WageWorks, Inc.
WAGE
| $3.99M | 0.01% |
98,530
+3,041
| +3% | +$141K |
|
|
MNTA
1703
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.97M | 0.01% |
174,109
+34,835
| +25% | +$694K |
|
|
IMS
1704
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $3.97M | 0.01% |
129,531
+62,556
| +93% | +$1.81M |
|
1705
Tronox
TROX
$1.02B
| $3.96M | 0.01% |
270,774
+32,119
| +13% | +$605K |
|
1706
DHI Group
DHX
$166M
| $3.96M | 0.01% |
445,468
+3,340
| +0.8% | +$29K |
|
1707
Strategic Education
STRA
$1.81B
| $3.93M | 0.01% |
91,086
+2,299
| +3% | +$113K |
|
|
ALOG
1708
DELISTED
Analogic Corp
ALOG
| $3.92M | 0.01% |
49,729
+2,285
| +5% | +$193K |
|
|
AHT
1709
Ashford Hospitality Trust
AHT
$20.3M
| $3.92M | 0.01% |
469
-41
| -8% | -$362K |
|
1710
Methode Electronics
MEI
$595M
| $3.92M | 0.01% |
142,844
+31,047
| +28% | +$1.39M |
|
1711
Omnicell
OMCL
$1.68B
| $3.92M | 0.01% |
103,891
+3,105
| +3% | +$113K |
|
|
KRA
1712
DELISTED
Kraton Corporation
KRA
| $3.9M | 0.01% |
163,194
+5,586
| +4% | +$126K |
|
1713
Pegasystems
PEGA
$5.44B
| $3.89M | 0.01% |
339,772
-147,862
| -30% | -$1.63M |
|
1714
Erie Indemnity
ERIE
$13.4B
| $3.88M | 0.01% |
47,235
+3,578
| +8% | +$296K |
|
1715
Astronics
ATRO
$3.7B
| $3.87M | 0.01% |
99,619
+3,087
| +3% | +$122K |
|
1716
ICU Medical
ICUI
$4.55B
| $3.87M | 0.01% |
40,422
-10,372
| -20% | -$969K |
|
1717
Saia
SAIA
$9.52B
| $3.87M | 0.01% |
98,382
+6,710
| +7% | +$277K |
|
|
ASRT
1718
DELISTED
Assertio
ASRT
| $3.86M | 0.01% |
3,001
+92
| +3% | +$126K |
|
|
HSII
1719
DELISTED
Heidrick & Struggles
HSII
| $3.85M | 0.01% |
147,572
+2,117
| +1% | +$52.9K |
|
|
FRGI
1720
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $3.85M | 0.01% |
76,941
+2,316
| +3% | +$122K |
|
|
PEGI
1721
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $3.85M | 0.01% |
135,471
+4,222
| +3% | +$123K |
|
|
S
1722
DELISTED
Sprint Corporation
S
| $3.84M | 0.01% |
841,128
-452,090
| -35% | -$2.18M |
|
|
CAA
1723
DELISTED
CalAtlantic Group, Inc.
CAA
| $3.83M | 0.01% |
86,060
+2,644
| +3% | +$112K |
|
1724
Sarepta Therapeutics
SRPT
$1.92B
| $3.83M | 0.01% |
125,848
+15,536
| +14% | +$318K |
|
1725
Quanex
NX
$1.01B
| $3.82M | 0.01% |
178,377
+9,322
| +6% | +$180K |
|
Similar funds
Charles Schwab's Q2 2015 Portfolio in Review
As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
- Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
- Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
- Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
- Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
- Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
- Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.
Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.